Pancreatic Cancer Research

ResearcherEvestra, Inc.Active in the last 2 years

Hareesh B Nair

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0364-7518; OpenAlex author ID A5102791014; NIH RePORTER profile ID 12113940. Sources: OpenAlex.

Their work

Papers
1
Trials
0
Grants
1
Labs led
0
Collaborators
12
Papers, trials and grants by year

2021: 1 grant · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 1

  1. Targeting cancer-associated fibroblast-driven LIF/LIFR axis improves the therapeutic efficacy of gemcitabine and nab-paclitaxel in pancreatic cancer. Co-author DOI 10.1038/s41698-025-01046-w↗

Grants 1

  1. Targeting LIF/LIFR in pancreatic cancer R44CA235991↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sushil Kumar · 1 shared grant, 2021 · strength 0.56
  2. Parthasarathy Seshacharyulu · 1 shared paper, 2025 · strength 0.21
  3. Sushil Kumar · 1 shared paper, 2025 · strength 0.21
  4. Namita Bhyravbhatla · 1 shared paper, 2025 · strength 0.21
  5. Shailendra Kumar Gautam · 1 shared paper, 2025 · strength 0.21
  6. Xiaoqi Li Li · 1 shared paper, 2025 · strength 0.21
  7. Zahraa Wajih Alsafwani · 1 shared paper, 2025 · strength 0.21
  8. Rick Bhatia · 1 shared paper, 2025 · strength 0.21
  9. Mokenge Peter Malafa · 1 shared paper, 2025 · strength 0.21
  10. Surinder K. Batra · 1 shared paper, 2025 · strength 0.21
  11. Maneesh Jain · 1 shared paper, 2025 · strength 0.21
  12. Moorthy Palanimuthu Ponnusamy · 1 shared paper, 2025 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.